Anterior cingulate cortex dysfunction underlies anxiety-like behaviors in MT2-deficient mice

Xiaodan Wang1, Lixia Zhuo2, Wei Wu2

  • 1Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China; Center for Brain Science, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Neuropharmacology
|August 24, 2025
PubMed

Insights

Melatonin MT2 receptor deficiency causes anxiety-like behaviors by disrupting the anterior cingulate cortex (ACC). Restoring MT2 signaling in the ACC alleviates these anxiety phenotypes, suggesting a therapeutic target.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Molecular Biology

Background:

  • Anxiety disorders significantly impact quality of life.
  • The melatonin type 2 receptor (MT2) is linked to anxiety, but its precise role is unknown.
  • Neural mechanisms underlying anxiety require further elucidation.

Purpose of the Study:

  • To investigate the role of MT2 in anxiety-like behaviors.
  • To determine the neural mechanisms mediated by MT2 in the anterior cingulate cortex (ACC).
  • To explore MT2 as a potential therapeutic target for anxiety disorders.

Main Methods:

  • Utilized global knockout (MT2-KO) and ACC-specific conditional knockout (MT2-cKO) mouse models.
  • Assessed anxiety-like phenotypes using standardized behavioral tests.
  • Performed electrophysiological recordings to analyze neuronal function.
  • Employed chemogenetics to manipulate MT2-positive neurons in the ACC.

Main Results:

  • MT2 deficiency robustly induced anxiety-like phenotypes in mice.
  • ACC dysfunction was identified as a key mediator of these anxiety behaviors.
  • MT2 deficiency disrupted the excitatory-inhibitory (E/I) balance in ACC pyramidal neurons.
  • Chemogenetic activation of ACC MT2 neurons restored E/I balance and reduced anxiety in a chronic stress model.

Conclusions:

  • MT2 is a critical regulator of ACC neurocircuitry and emotional regulation.
  • Targeting ACC MT2 signaling offers a potential therapeutic strategy for anxiety disorders.